A New 20% Concentration Immunoglobulin for Subcutaneous Administration (IGSC 20%)

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.045
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Improved Treatment Satisfaction With a New Human Subcutaneous Immunoglobulin (SCIG 20%) in Patients Previously Treated With IVIG

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Untreated for 20 Years: A 14 Kilogram Subcutaneous Lipoma

WORLD JOURNAL OF PLASTIC SURGERY
2018English

ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase 20

Drug Delivery
MedicinePharmaceutical Science
2019English

Hindsight Is 20/20

Journal of Hospital Medicine
Internal MedicineCare PlanningHealth PolicyFundamentalsSkillsLeadershipManagementDiagnosisMedicineAssessment
2020English

5:20:20:5 Efficiency

PUPIL: International Journal of Teaching, Education and Learning
2018English

Rapid Push: New Opportunities in Subcutaneous Immunoglobulin Replacement Therapy

Central-European Journal of Immunology
AllergyImmunology
2013English

Vision 20∕20: Proton Therapy

Medical Physics
MedicineNuclear MedicineRadiologyImagingBiophysics
2009English

The Use of Rocuronium 20 Minutes After Sugammadex Administration - A Case Report

Global Anesthesia and Perioperative Medicine
2015English

20/20 Vision: Creating Our Future

AORN Journal
Surgical NursingMedical
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy